Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 13Esophageal Neoplasms 7Rectal Neoplasms 6Colorectal Neoplasms 6Adenocarcinoma Of Esophagus 6Nasopharyngeal Carcinoma 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Polyps 3Lung Neoplasms 3Precancerous Conditions 2Pathologic Complete Response 2Hyperplasia 2Gastroesophageal Reflux 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Adenomatous Polyposis Coli 2Adenocarcinoma 2Urogenital Neoplasms 1Upper Tract Urothelial Carcinoma 1Thyroid Neoplasms 1Stomach Ulcer 1Stomach Diseases 1Recurrence 1Polyposis, Gastric 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Metaplasia 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1alovudine 1Tirzepatide 1Restraint, Physical 1Microspheres 1Metformin 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hyperplasia × Endoscopy × Clear all
NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡